Following 5a treatment, two types of breast cancer cells (HER2-positive and EGFR-positive) were noticeably arrested in the G1 phase of the cell cycle, with a concomitant loss of the S- and G2/M-phase cell populations (Figure 3a). The gene discussed is EGFR; the disease is breast cancer.